You are on page 1of 2

Calendar Quarter Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012


Milestones and Events NAV4694 NAV5001 Alzheimers Parkinsons

RIGscan CR


NEO3-09 Top-Line Data May Full Data at ASCO in June NDA Submission

EMA Scientific

Notification of PDUFA

In-License Sign Option

Option date June 30th

EMA Guidance ASCO Data Presentation Interim Data NEO3-06

FDA PDUFA September 10th FDA NDA Resubmission EMA MAA Submission

Begin Phase IIb

Extended Option to July 31st Option Exercised

Q4 2012 Q1 2013

FDA Approval March 13

(PDUFA April 30)

Data Phase IIb

Calendar Quarter Q2 2013

Lymphoseek EU Marketing Partnerships US Product Launch Interim Data NEO3-06

(DSMB recommends early trial termination)

Q3 2013 Q4 2013 EU Approval and Launch Final Data NEO3-06

Milestones and Events NAV4694 NAV5001 Alzheimers Parkinsons Begin Phase IIb Begin Phase IIb Dementia with Lewy Mild Cognitive Bodies Impairment Begin Phase III Dementia Begin Phase III Movement Disorders Data Phase IIb Mild Cognitive Impairment Data Phase III Dementia FDA Submission FDA Approval

RIGscan CR Begin Phase II

Data Phase II Begin NEO2-17 Phase III

H1 2014

H2 2014 H1 2015

Data Phase IIb Dementia with Lewy Bodies Data Phase III Movement Disorder FDA Submission

H2 2015

FDA Approval

Data NEO2-17 BLA Submission FDA Approval